deltatrials
Terminated PHASE2 NCT04475991

Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults

Phase2, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Maraviroc and/or Favipiravir Plus Standard Therapy in Adult Patients With Severe Non-critical COVID-19

Sponsor: CCINSHAE. Secretaría de Salud. México

Conditions COVID-19
Interventions Curently used therapy for COVID-19 non-critical patients Favipiravir + Currently used therapy Maraviroc + Currently used therapy Maraviroc+Favipiravir+CT
Updated 13 times since 2020 Last updated: May 31, 2022 Started: Jul 13, 2021 Primary completion: Mar 15, 2022 Completion: Mar 25, 2022

This PHASE2 trial investigates COVID-19 and is currently terminated or withdrawn. CCINSHAE. Secretaría de Salud. México leads this study, which shows 13 recorded versions since 2021 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~May 2021 · 2 months · monthly snapshot~May 2021 – ~Sep 2021 · 4 months · monthly snapshot~Sep 2021 – ~Apr 2022 · 7 months · monthly snapshot~Apr 2022 – ~Jul 2022 · 3 months · monthly snapshot~Jul 2022 – ~Jul 2024 · 24 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 19 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jul 2022 — Jul 2024 [monthly]

    Terminated PHASE2

    Status: Recruiting → Terminated

  4. Apr 2022 — Jul 2022 [monthly]

    Recruiting PHASE2

  5. Sep 2021 — Apr 2022 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

▶ Show 8 earlier versions

  1. May 2021 — Sep 2021 [monthly]

    Not Yet Recruiting PHASE2

  2. Mar 2021 — May 2021 [monthly]

    Not Yet Recruiting PHASE2

  3. Jan 2021 — Mar 2021 [monthly]

    Not Yet Recruiting PHASE2

  4. Dec 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE2

  5. Nov 2020 — Dec 2020 [monthly]

    Not Yet Recruiting PHASE2

  6. Oct 2020 — Nov 2020 [monthly]

    Not Yet Recruiting PHASE2

  7. Sep 2020 — Oct 2020 [monthly]

    Not Yet Recruiting PHASE2

  8. Aug 2020 — Sep 2020 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CCINSHAE. Secretaría de Salud. México
  • Centro de Investigación en. Enfermedades Infecciosas, Mexico
  • Hospital General de México Dr. Eduardo Liceaga
  • Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Data source: Hospital General de México Dr. Eduardo Liceaga

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations